{
  "resourceType" : "Bundle",
  "id" : "mii-exa-befund-bundle-befund-fgfr2-fusion",
  "language" : "de",
  "type" : "transaction",
  "timestamp" : "2022-12-16T13:47:00+01:00",
  "entry" : [{
    "fullUrl" : "https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-patient-fgfr2-fusion",
    "resource" : {
      "resourceType" : "Patient",
      "id" : "mii-exa-molgen-patient-fgfr2-fusion",
      "language" : "de",
      "text" : {
        "status" : "generated"
      },
      "identifier" : [{
        "use" : "usual",
        "type" : {
          "coding" : [{
            "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationValue",
            "code" : "PSEUDED"
          }]
        },
        "system" : "https://www.charite.de/fhir/sid/pseudonym",
        "value" : "3337167192"
      }],
      "gender" : "female",
      "birthDate" : "1964-05",
      "deceasedBoolean" : false,
      "address" : [{
        "type" : "both",
        "postalCode" : "10",
        "country" : "DE"
      }]
    },
    "request" : {
      "method" : "PUT",
      "url" : "Patient/mii-exa-molgen-patient-fgfr2-fusion"
    }
  },
  {
    "fullUrl" : "https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-practitioner-lab",
    "resource" : {
      "resourceType" : "Practitioner",
      "id" : "mii-exa-molgen-practitioner-lab",
      "language" : "de",
      "text" : {
        "status" : "generated"
      },
      "active" : true,
      "name" : [{
        "use" : "official",
        "text" : "Dr. Daniel Schmidt",
        "family" : "Schmidt",
        "given" : ["Daniel"],
        "prefix" : ["Dr."]
      }]
    },
    "request" : {
      "method" : "PUT",
      "url" : "Practitioner/mii-exa-molgen-practitioner-lab"
    }
  },
  {
    "fullUrl" : "https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-practitioner-physician",
    "resource" : {
      "resourceType" : "Practitioner",
      "id" : "mii-exa-molgen-practitioner-physician",
      "language" : "de",
      "text" : {
        "status" : "generated"
      },
      "active" : true,
      "name" : [{
        "use" : "official",
        "text" : "Dr. Linda Rubens",
        "family" : "Rubens",
        "given" : ["Linda"],
        "prefix" : ["Dr."]
      }]
    },
    "request" : {
      "method" : "PUT",
      "url" : "Practitioner/mii-exa-molgen-practitioner-physician"
    }
  },
  {
    "fullUrl" : "https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-befundbericht-fgfr2-fusion",
    "resource" : {
      "resourceType" : "DiagnosticReport",
      "id" : "mii-exa-molgen-befundbericht-fgfr2-fusion",
      "meta" : {
        "profile" : ["https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/molekulargenetischer-befundbericht|2027.0.0-ballot.1",
        "http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/genomic-report|3.0.0"]
      },
      "language" : "de",
      "text" : {
        "status" : "generated"
      },
      "extension" : [{
        "url" : "http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/recommended-action",
        "valueReference" : {
          "reference" : "Task/mii-exa-molgen-medikationsempfehlung-fgfr2-fusion"
        }
      }],
      "basedOn" : [{
        "reference" : "ServiceRequest/mii-exa-molgen-anforderung-fgfr2-fusion"
      }],
      "status" : "final",
      "category" : [{
        "coding" : [{
          "system" : "http://terminology.hl7.org/CodeSystem/v2-0074",
          "code" : "GE",
          "display" : "Genetics"
        }]
      }],
      "code" : {
        "coding" : [{
          "system" : "http://loinc.org",
          "code" : "51969-4",
          "display" : "Genetic analysis report"
        }]
      },
      "subject" : {
        "reference" : "Patient/mii-exa-molgen-patient-fgfr2-fusion"
      },
      "performer" : [{
        "reference" : "Practitioner/mii-exa-molgen-practitioner-lab"
      }],
      "result" : [{
        "reference" : "Observation/mii-exa-molgen-diagnostische-implikation-fgfr2-fusion"
      },
      {
        "reference" : "Observation/mii-exa-molgen-variante-fgfr2-fusion"
      },
      {
        "reference" : "Observation/mii-exa-molgen-therapeutische-implikation-fgfr2-fusion"
      }],
      "conclusion" : "Nachweis FGFR2-Fusion. Empfehlung: Hochselektive FGFR-Inhibitor-Therapie."
    },
    "request" : {
      "method" : "PUT",
      "url" : "DiagnosticReport/mii-exa-molgen-befundbericht-fgfr2-fusion"
    }
  },
  {
    "fullUrl" : "https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-anforderung-fgfr2-fusion",
    "resource" : {
      "resourceType" : "ServiceRequest",
      "id" : "mii-exa-molgen-anforderung-fgfr2-fusion",
      "meta" : {
        "profile" : ["https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/anforderung-genetischer-test|2027.0.0-ballot.1"]
      },
      "language" : "de",
      "text" : {
        "status" : "generated"
      },
      "identifier" : [{
        "system" : "https://www.charite.de/fhir/auftragsnummern",
        "value" : "PRK4QE59A"
      }],
      "status" : "active",
      "intent" : "order",
      "category" : [{
        "coding" : [{
          "system" : "http://snomed.info/sct",
          "code" : "108252007",
          "display" : "Laboratory procedure (procedure)"
        }]
      }],
      "code" : {
        "coding" : [{
          "system" : "http://snomed.info/sct",
          "code" : "405825005",
          "display" : "Molecular genetic test (procedure)"
        }],
        "text" : "Therapierelevante genetische Veränderungen bei Intrahepatischem Gallengangskarzinom"
      },
      "subject" : {
        "reference" : "Patient/mii-exa-molgen-patient-fgfr2-fusion"
      },
      "authoredOn" : "2022-11-30",
      "requester" : {
        "reference" : "Practitioner/mii-exa-molgen-practitioner-physician"
      },
      "reasonCode" : [{
        "coding" : [{
          "system" : "http://snomed.info/sct",
          "code" : "109842005",
          "display" : "Intrahepatic bile duct carcinoma (disorder)"
        },
        {
          "system" : "http://fhir.de/CodeSystem/bfarm/icd-10-gm",
          "version" : "2024",
          "code" : "C22.1",
          "display" : "Intrahepatisches Gallengangskarzinom"
        }]
      }]
    },
    "request" : {
      "method" : "PUT",
      "url" : "ServiceRequest/mii-exa-molgen-anforderung-fgfr2-fusion"
    }
  },
  {
    "fullUrl" : "https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-variante-fgfr2-fusion",
    "resource" : {
      "resourceType" : "Observation",
      "id" : "mii-exa-molgen-variante-fgfr2-fusion",
      "meta" : {
        "profile" : ["https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/variante|2027.0.0-ballot.1",
        "http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/variant|3.0.0"]
      },
      "language" : "de",
      "text" : {
        "status" : "generated"
      },
      "basedOn" : [{
        "reference" : "ServiceRequest/mii-exa-molgen-anforderung-fgfr2-fusion"
      }],
      "status" : "final",
      "category" : [{
        "coding" : [{
          "system" : "http://terminology.hl7.org/CodeSystem/observation-category",
          "code" : "laboratory",
          "display" : "Laboratory"
        }]
      },
      {
        "coding" : [{
          "system" : "http://terminology.hl7.org/CodeSystem/v2-0074",
          "code" : "GE"
        }]
      }],
      "code" : {
        "coding" : [{
          "system" : "http://loinc.org",
          "code" : "69548-6",
          "display" : "Genetic variant assessment"
        }]
      },
      "subject" : {
        "reference" : "Patient/mii-exa-molgen-patient-fgfr2-fusion"
      },
      "effectiveDateTime" : "2022-11-30",
      "valueCodeableConcept" : {
        "coding" : [{
          "system" : "http://loinc.org",
          "code" : "LA9633-4",
          "display" : "Present"
        }]
      },
      "method" : {
        "coding" : [{
          "system" : "http://loinc.org",
          "code" : "LA26398-0",
          "display" : "Sequencing"
        },
        {
          "system" : "http://loinc.org",
          "code" : "86206-0",
          "display" : "Whole genome sequence analysis in Blood or Tissue by Molecular genetics method"
        }]
      },
      "component" : [{
        "code" : {
          "coding" : [{
            "system" : "http://loinc.org",
            "code" : "48018-6"
          }]
        },
        "valueCodeableConcept" : {
          "coding" : [{
            "system" : "http://www.genenames.org/geneId",
            "code" : "HGNC:3689",
            "display" : "FGFR2"
          }]
        }
      },
      {
        "code" : {
          "coding" : [{
            "system" : "http://loinc.org",
            "code" : "48019-4"
          }]
        },
        "valueCodeableConcept" : {
          "coding" : [{
            "system" : "http://sequenceontology.org",
            "code" : "SO:0001565",
            "display" : "gene_fusion"
          }]
        }
      },
      {
        "code" : {
          "coding" : [{
            "system" : "http://loinc.org",
            "code" : "95123-6"
          }]
        },
        "valueCodeableConcept" : {
          "coding" : [{
            "system" : "http://www.genenames.org/geneId",
            "code" : "HGNC:3689::HGNC:2697",
            "display" : "FGFR2::DBP"
          }]
        }
      }]
    },
    "request" : {
      "method" : "PUT",
      "url" : "Observation/mii-exa-molgen-variante-fgfr2-fusion"
    }
  },
  {
    "fullUrl" : "https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-diagnostische-implikation-fgfr2-fusion",
    "resource" : {
      "resourceType" : "Observation",
      "id" : "mii-exa-molgen-diagnostische-implikation-fgfr2-fusion",
      "meta" : {
        "profile" : ["https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/diagnostische-implikation|2027.0.0-ballot.1",
        "http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/diagnostic-implication|3.0.0"]
      },
      "language" : "de",
      "text" : {
        "status" : "generated"
      },
      "status" : "final",
      "category" : [{
        "coding" : [{
          "system" : "http://terminology.hl7.org/CodeSystem/observation-category",
          "code" : "laboratory",
          "display" : "Laboratory"
        }]
      },
      {
        "coding" : [{
          "system" : "http://terminology.hl7.org/CodeSystem/v2-0074",
          "code" : "GE"
        }]
      }],
      "code" : {
        "coding" : [{
          "system" : "http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs",
          "code" : "diagnostic-implication",
          "display" : "Diagnostic Implication"
        }]
      },
      "subject" : {
        "reference" : "Patient/mii-exa-molgen-patient-fgfr2-fusion"
      },
      "effectiveDateTime" : "2022-11-30",
      "performer" : [{
        "reference" : "Practitioner/mii-exa-molgen-practitioner-lab"
      }],
      "derivedFrom" : [{
        "reference" : "Observation/mii-exa-molgen-variante-fgfr2-fusion"
      }],
      "component" : [{
        "code" : {
          "coding" : [{
            "system" : "http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs",
            "code" : "conclusion-string"
          }]
        },
        "valueString" : "starke Überexpression (25-fach)"
      }]
    },
    "request" : {
      "method" : "PUT",
      "url" : "Observation/mii-exa-molgen-diagnostische-implikation-fgfr2-fusion"
    }
  },
  {
    "fullUrl" : "https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-therapeutische-implikation-fgfr2-fusion",
    "resource" : {
      "resourceType" : "Observation",
      "id" : "mii-exa-molgen-therapeutische-implikation-fgfr2-fusion",
      "meta" : {
        "profile" : ["https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/therapeutische-implikation|2027.0.0-ballot.1",
        "http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/therapeutic-implication|3.0.0"]
      },
      "language" : "de",
      "text" : {
        "status" : "generated"
      },
      "status" : "final",
      "category" : [{
        "coding" : [{
          "system" : "http://terminology.hl7.org/CodeSystem/observation-category",
          "code" : "laboratory",
          "display" : "Laboratory"
        }]
      },
      {
        "coding" : [{
          "system" : "http://terminology.hl7.org/CodeSystem/v2-0074",
          "code" : "GE"
        }]
      }],
      "code" : {
        "coding" : [{
          "system" : "http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs",
          "code" : "therapeutic-implication",
          "display" : "Therapeutic Implication"
        }]
      },
      "subject" : {
        "reference" : "Patient/mii-exa-molgen-patient-fgfr2-fusion"
      },
      "effectiveDateTime" : "2022-11-30",
      "performer" : [{
        "reference" : "Practitioner/mii-exa-molgen-practitioner-lab"
      }],
      "derivedFrom" : [{
        "reference" : "Observation/mii-exa-molgen-variante-fgfr2-fusion"
      }],
      "component" : [{
        "code" : {
          "coding" : [{
            "system" : "http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs",
            "code" : "conclusion-string"
          }]
        },
        "valueString" : "Hochselektiver FGFR2-Inhibitor RLY-4008 bei Patienten mit Cholangiokarzinomen und anderen soliden Tumoren, mit oder ohne FGFR- gerichtete Vortherapie."
      },
      {
        "code" : {
          "coding" : [{
            "system" : "http://loinc.org",
            "code" : "51963-7",
            "display" : "Medication assessed [ID]"
          }]
        },
        "valueCodeableConcept" : {
          "coding" : [{
            "system" : "http://www.whocc.no/atc",
            "code" : "L01EN",
            "display" : "Fibroblasten-Wachstumsfaktor-Rezeptor (FGFR)-Tyrosinkinase-Inhibitoren"
          },
          {
            "system" : "http://snomed.info/sct",
            "code" : "1162485005",
            "display" : "Substance with fibroblast growth factor receptor inhibitor mechanism of action (substance)"
          }]
        }
      },
      {
        "code" : {
          "coding" : [{
            "system" : "http://loinc.org",
            "code" : "93044-6"
          }]
        },
        "valueCodeableConcept" : {
          "text" : "m1c"
        }
      },
      {
        "code" : {
          "coding" : [{
            "system" : "http://loinc.org",
            "code" : "81259-4"
          }]
        },
        "valueCodeableConcept" : {
          "coding" : [{
            "system" : "http://snomed.info/sct",
            "code" : "109842005",
            "display" : "Intrahepatic bile duct carcinoma (disorder)"
          },
          {
            "system" : "http://fhir.de/CodeSystem/bfarm/icd-10-gm",
            "version" : "2024",
            "code" : "C22.1",
            "display" : "Intrahepatisches Gallengangskarzinom"
          }]
        }
      }]
    },
    "request" : {
      "method" : "PUT",
      "url" : "Observation/mii-exa-molgen-therapeutische-implikation-fgfr2-fusion"
    }
  },
  {
    "fullUrl" : "https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-medikationsempfehlung-fgfr2-fusion",
    "resource" : {
      "resourceType" : "Task",
      "id" : "mii-exa-molgen-medikationsempfehlung-fgfr2-fusion",
      "meta" : {
        "profile" : ["https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/medikationsempfehlung|2027.0.0-ballot.1",
        "http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/medication-recommendation|3.0.0"]
      },
      "language" : "de",
      "text" : {
        "status" : "generated"
      },
      "basedOn" : [{
        "reference" : "ServiceRequest/mii-exa-molgen-anforderung-fgfr2-fusion"
      }],
      "status" : "requested",
      "intent" : "proposal",
      "code" : {
        "coding" : [{
          "system" : "http://loinc.org",
          "code" : "LA26421-0",
          "display" : "Consider alternative medication"
        }],
        "text" : "Hochselektive FGFR-Inhibitor-Therapie"
      },
      "for" : {
        "reference" : "Patient/mii-exa-molgen-patient-fgfr2-fusion"
      },
      "reasonReference" : {
        "reference" : "Observation/mii-exa-molgen-therapeutische-implikation-fgfr2-fusion"
      }
    },
    "request" : {
      "method" : "PUT",
      "url" : "Task/mii-exa-molgen-medikationsempfehlung-fgfr2-fusion"
    }
  }]
}